RC278
/ RemeGen
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
November 27, 2025
A I/II Phase Clinical Study to Evaluate the Safety and Efficacy of RC278 in the Treatment of Solid Tumors
(clinicaltrials.gov)
- P1/2 | N=312 | Recruiting | Sponsor: RemeGen Co., Ltd. | Not yet recruiting ➔ Recruiting
Enrollment open • Solid Tumor
August 06, 2025
A I/II Phase Clinical Study to Evaluate the Safety and Efficacy of RC278 in the Treatment of Solid Tumors
(clinicaltrials.gov)
- P1/2 | N=312 | Not yet recruiting | Sponsor: RemeGen Co., Ltd.
New P1/2 trial • Solid Tumor
1 to 2
Of
2
Go to page
1